Monthly Archives: December 2016

Potential Mesothelioma Treatment Uses Breast Cancer Drug Tamoxifen

Possible Mesothelioma Treatment Uses Breast Cancer Drug Tamoxifen

Tamoxifen is a drug commonly given to both men and women who have breast cancer. It might someday also be given to mesothelioma patients. It turns out that the main ingredient of tamoxifen seems to work against mesothelioma tumors. The main ingredient in tamoxifen blocks estrogen. Breast cancer feeds off estrogen. Apparently so does mesothelioma.

Continue Reading →
Trabectedin May Be FDA-Approved As a Mesothelioma Chemo Drug in the Future

Trabectedin May Be FDA-Approved As a Mesothelioma Chemo Drug in the Future

There are just a handful of chemotherapy agents approved by the U.S. Food and Drug Administration (FDA) for the treatment of mesothelioma. Right now the FDA-approved chemotherapy drugs for mesothelioma are cisplatin, carboplatin, gemcitabine and pemetrexed. But there eventually might be one more to add to that list, thanks to new research making the case

Continue Reading →
Study on Mesothelioma Survival Confirms Chemo Helps

Study on Mesothelioma Survival Confirms Chemo Helps

You’re likely to survive mesothelioma longer if you have some form of chemotherapy. This is true no matter what stage your mesothelioma is in when you start chemotherapy. You’re likely to survive mesothelioma even longer if you have chemotherapy paired up with surgery. That seems pretty self-evident. But the evidence in support of such claims

Continue Reading →
Chemotherapy Combines with Resveratrol for Effective Attack on Mesothelioma

Chemotherapy Combines with Resveratrol for Effective Attack on Mesothelioma

One of the chemicals found naturally in red wine is called resveratrol. It turns out that combining resveratrol with the chemotherapy drug cisplatin makes the chemo drug more effective against mesothelioma. Researchers from Soonchunhyang University in Cheonan, South Korea, were the ones to make this discovery. They said they were excited about this finding because

Continue Reading →
Targovax Keeps Working on Mesothelioma Drug ONCOS-102

Targovax Keeps Working on Mesothelioma Drug ONCOS-102

The company behind ONCOS-102 gave scientists at the recent big meeting of the European Society of Gene and Cell Therapy some reasons why it’s continuing to work on this mesothelioma immunotherapy drug. First, the company said there’s a big need to develop better mesothelioma treatments. Mesothelioma is a rare form of cancer. So it gets

Continue Reading →
Desmoplastic Mesothelioma Is Rarest Subtype, and Hardest to Treat

Desmoplastic Mesothelioma Is Rarest Subtype and Hardest to Treat

It’s important to know which mesothelioma subtype you have. The reason is that the ideal treatment is a little different for each subtype. And, even though the differences are small, they can matter a lot when it comes to helping you survive with mesothelioma for a longer period of time. You probably already know that

Continue Reading →
Glycodelin Is Possible Biomarker for Detecting Mesothelioma Earlier

Glycodelin Is Possible Biomarker for Detecting Mesothelioma Earlier

Mesothelioma is a cancer that becomes harder to fight the longer it goes undetected within you. For that reason, cancer specialists recommend that people without mesothelioma get checked for it regularly if they were ever exposed to asbestos. Asbestos exposure is the cause of mesothelioma. The idea is that you want to be able to

Continue Reading →